login
A106442
Exponent-recursed cross-domain bijection from N to GF(2)[X]. Position of A075166(n) in A106456.
11
0, 1, 2, 3, 4, 7, 6, 11, 8, 5, 14, 13, 12, 19, 22, 9, 16, 25, 10, 31, 28, 29, 26, 37, 24, 21, 38, 15, 44, 41, 18, 47, 128, 23, 50, 49, 20, 55, 62, 53, 56, 59, 58, 61, 52, 27, 74, 67, 192, 69, 42, 43, 76, 73, 30, 35, 88, 33, 82, 87, 36, 91, 94, 39, 64, 121, 46, 97, 100, 111, 98
OFFSET
0,3
COMMENTS
This map from the multiplicative domain of N to that of GF(2)[X] preserves Catalan-family structures, e.g. A106454(n) = a(A075164(n)), A075163(n) = A106453(a(n)), A075165(n) = A106455(a(n)), A075166(n) = A106456(a(n)), A075167(n) = A106457(a(n)). Shares with A091202 and A106444 the property that maps A000040(n) to A014580(n). Differs from the former for the first time at n=32, where A091202(32)=32, while a(32)=128. Differs from the latter for the first time at n=48, where A106444(48)=48, while a(48)=192.
FORMULA
a(0)=0, a(1)=1, a(p_i) = A014580(i) for primes p_i with index i and for composites n = p_i^e_i * p_j^e_j * p_k^e_k * ..., a(n) = A048723(a(p_i), a(e_i)) X A048723(a(p_j), a(1+e_j)-1) X A048723(a(p_k), a(1+e_k)-1) X ..., where X stands for carryless multiplication of GF(2)[X] polynomials (A048720) and A048723(n, y) raises the n-th GF(2)[X] polynomial to the y:th power. Here p_i is the most significant prime in the factorization of n; its exponent e_i is not incremented before the recursion step, while the exponents of less significant primes e_j, e_k, ... are incremented by one before recursing and the result of the recursion is decremented by one before use.
EXAMPLE
a(5) = 7, as 5 is the 3rd prime and the third irreducible GF(2)[X] polynomial x^2+x+1 is encoded as A014580(3) = 7. a(32) = a(2^5) = A048723(A014580(1),a(5)) = A048723(2,7) = 128. a(48) = a(3 * 2^4) = 3 X A048723(2,a(4+1)-1) = 3 X A048723(2,7-1) = 3 X 64 = 192.
CROSSREFS
Inverse: A106443. a(n) = A106454(A075163(n)).
Sequence in context: A374991 A091202 A106444 * A091204 A106446 A321220
KEYWORD
nonn
AUTHOR
Antti Karttunen, May 09 2005
STATUS
approved